COLURACETAM

  * Marked fields are required.
Qty*
Price $24.95
Availability In-Stock

 15ML  50MG/ML

This product is for research only and not for human consumption.

CHEMICAL NAME: N-(2,3-dimethyl-5,6,7,8- tetrahydrofuro[2,3-b] quinolin-4-yl)-2- (2-oxopyrrolidin-1-yl)acetamide
MOLECULAR FORMULA: C19H23N3O3
CAS NUMBER: 135463-81-9
MOLECULAR MASS: 341.40 g/mol
STORAGE: Store in room temperature out of direct light

1ML extractor syringe is included with each order for your convince but more can be added to your shopping cart.

 

Coluracetam (BCI-540) is a nootropic drug of the racetam family Coluracetam (formerly known as MKC-231) was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California.Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD). BrainCells Inc is currently out-licensing the drug for this purpose. It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.

Mechanism of Action

Coluracetam enhances high-affinity choline uptake (HACU) which is the rate-limiting step of acetylcholine (ACh) synthesis, and is the only known choline uptake enhancer to currently exist. Studies have shown Coluracetam to improve learning impairment on a single oral dose given to rats which have been exposed to cholinergic neurotoxins. Subsequent studies have shown that it may induce long-lasting procognitive effects by changing the choline transporter regulation system.